Editor's Note

Welcome to the fourth issue of Xtalks Clinical Edge™ — where innovation meets expertise!

In this edition, and in future issues, we delve into next-generation clinical research. We aim to equip industry stakeholders with the insights needed to stay ahead and leverage innovations that enhance efficiency, improve patient outcomes and accelerate the development of transformative therapies.

This issue features exclusive interviews with key opinion leaders, including experts from the FDA’s Center for Drug Evaluation and Research (CDER), who provide an in-depth look at the evolving landscape of digital health technologies (DHTs) and their regulatory implications. We also present insights from the Digital Medicine Society (DiMe) on integrating digital endpoints in clinical research, highlighting both the opportunities and challenges of incorporating digital tools in clinical trials.

In addition, senior leaders from a range of organizations — from emerging biotechs to established pharma companies like AstraZeneca and Takeda, as well as innovators such as Click Therapeutics and Alto Neuroscience — share their experiences, strategies and visions for the future of clinical research.

Each quarter, Xtalks Clinical Edge™ brings you conversations with influential figures and pioneers within the clinical trials community, offering valuable insights into the dynamic field of clinical research.

As you explore this issue, we hope you gain a deeper understanding of the trends shaping the future of clinical trials.

Mark your calendar for our next issue, arriving in June 2025.